Davis Aaron I.
SEC CIK 1465914 · EDGAR
BoughtSold
Most active insiders at TNGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRV GP IV, LLC | 10% | — | $8.86M |
| 2 | Crystal Adam | Pres, R, D | — | $6.33M |
| 3 | Weber Barbara | Dir, Executive COB | — | $374.4K |
| 4 | Newcomb Jessica | Principal Accounting Off | — | $198.6K |
| 5 | Beckman Daniella | CFO | — | $126.6K |
| 6 | Ketchum John B | Dir | — | — |
| 7 | Peters Malte | Pres, CEO, Dir | — | — |
| 8 | Rothenberg Mace | Dir | — | — |
| 9 | Gall Matthew | CFO | — | — |
| 10 | Lee Sung | Dir | — | — |
Davis Aaron I. made no open-market trades at TNGX in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2023-10-17 | 2023-10-13+ | TNGX | Tango Therapeutics, Inc. | Davis Aaron I. | See remarks | P - Purchase | $6.98 | +1.25M | 8.20M | +18% | +$8.72M |
| DAI | 2023-10-11 | 2023-08-11 | TNGX | Tango Therapeutics, Inc. | Davis Aaron I. | Dir, See remarks | A - Grant | $5.15 | +475.0K | 743.5K | +177% | +$2.45M |
| D | 2023-06-08 | 2023-06-06 | TNGX | Tango Therapeutics, Inc. | Davis Aaron I. | Dir | A - Grant | $0.00 | +5,000 | 5,000 | New | $0 |
| M | 2023-02-13 | 2023-02-09+ | TYRA | Tyra Biosciences, Inc. | Davis Aaron I. | 10% | S - Sale | $13.17 | -265.6K | 22.5K | -92% | -$3.50M |
Purchase Sale Sale after option exercise All abbreviations